Products/Services Used | Details | Operation |
---|---|---|
Peptide Synthesis | lRGD was purchased from Shanghai Sanguine Bioengineering Technology Service Co., Ltd., while cRGD was purchased from GenScript, and Bcl-2 siRNA was purchased from Santa Cruz Biotechnology, Inc. Ltd. | Get A Quote |
Small interfering RNA (siRNA) highlights the immense therapeutic potential for cancer treatment. The major challenge in siRNA therapy is the effective RNA nanodrug delivery system, which is facilitated by the ligand and the carrier. In this study, we analyzed the binding specificity of linear RGD and circular RGD to αVβ3 integrins by mapping the morphology using super-resolution direct stochastic optical reconstruction microscopy. Meanwhile, the binding dynamics was investigated using single-molecule force spectroscopy. Then, the effects of the ligand and carrier on RNA nanodrug cell entry dynamic parameters were evaluated at the single particle level by the force tracing technique. Furthermore, the delivery ... More